Member access

4-Traders Homepage  >  Shares  >  Oslo Bors  >  Photocure ASA    PHO   NO0010000045

PHOTOCURE ASA (PHO)

4
 SummaryChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Oslo Bors
02/23/2015 02/24/2015 02/25/2015 02/26/2015 02/27/2015 Date
36 35.2 34.5 34 34.1 Last
24601 37651 6471 20020 15999 Volume
+0.84% -2.22% -1.99% -1.45% +0.29% Change
Company
Photocure ASA develops and markets pharmaceuticals and medical devices based on proprietary photodynamic technology.It operates through the Cancer and Dermatology segments.The Cancer segment consists of the sale from Hexvix to pharmaceutical wholesalers in Nordic markets and Cysview in the United... 
Sector
Pharmaceuticals
Calendar
04/29Earnings Release
More about the company
Chart PHOTOCURE ASA
Duration : Period :
Photocure ASA Technical Analysis Chart | PHO | NO0010000045 | 4-Traders
Full-screen chart
Latest news on PHOTOCURE ASA
02/20 HUNTER HALL GLOBAL VALUE : Disclosure of shareholdings in Photocure
02/19 PHOTOCURE ASA : Announces Results For Fourth Quarter And Full Year 2014
02/19 PHOTOCURE ASA : Results for fourth quarter and full year 2014
02/16 PHOTOCURE ASA : Results for fourth quarter and full year 2014
02/09 PHOTOCURE ASA : Presentation of the fourth quarter and full year 2014 results
02/09 PHOTOCURE ASA : New data provide evidence that Hexvix® can improve the overall s..
01/13 PHOTOCURE ASA : Announces end of phase 2 status achieved for cevira in u.s.
2014 PHOTOCURE ASA : Exercise of employee share options
More news
Sector news Pharmaceuticals - NEC
05:01a SALIX PHARMACEUTICALS : SHAREHOLDER ALERT: Brower Piven Commences An Investigati..
02/27 JOHNSON & JOHNSON : Announces Formation of New Health and Wellness Platform Desi..
02/27 ABBOTT LABORATORIES : Mylan closes $5.3B tax-lowering deal with Abbott Labs
Plus d'actualités du secteur Pharmaceuticals - NEC


Comments 
Advertisement
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF